Matthew Gall

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Matthew Gall
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Gall:

Company Role Class Num Shares Value Price $ Report Date Ownership
iTeos Therapeutics, Inc. Chief Financial Officer Common Stock 0 $0 $10.21 29 Aug 2025 Direct
Kalaris Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 235,000 03 Nov 2025 Direct
iTeos Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 0 29 Aug 2025 Direct

Insider Reports Filed by Matthew Gall

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KLRS Kalaris Therapeutics, Inc. 03 Nov 2025 1 $0 4 Chief Financial Officer 03 Nov 2025, 17:25
KLRS Kalaris Therapeutics, Inc. 03 Nov 2025 0 $0 3 Chief Financial Officer 03 Nov 2025, 17:23
ITOS iTeos Therapeutics, Inc. 29 Aug 2025 6 $0 4 Chief Financial Officer 29 Aug 2025, 16:30
ITOS iTeos Therapeutics, Inc. 07 Mar 2025 2 $0 4 Chief Financial Officer 11 Mar 2025, 20:00
ITOS iTeos Therapeutics, Inc. 19 Nov 2024 1 +$38,635 4 Chief Financial Officer 19 Nov 2024, 19:59
ITOS iTeos Therapeutics, Inc. 07 Mar 2024 1 $0 4 Chief Financial Officer 08 Mar 2024, 20:01
ITOS iTeos Therapeutics, Inc. 05 Dec 2023 1 $0 4 Chief Financial Officer 07 Dec 2023, 20:21
ITOS iTeos Therapeutics, Inc. 12 Oct 2023 1 +$41,850 4 Chief Financial Officer 12 Oct 2023, 17:09
ITOS iTeos Therapeutics, Inc. 09 Mar 2023 1 $0 4 Chief Financial Officer 10 Mar 2023, 18:53
ITOS iTeos Therapeutics, Inc. 11 Mar 2022 1 $0 4 Chief Financial Officer 14 Mar 2022, 20:00
ITOS iTeos Therapeutics, Inc. 27 Dec 2021 1 -$232,250 4 Chief Financial Officer 28 Dec 2021, 19:58
ITOS iTeos Therapeutics, Inc. 11 Oct 2021 2 +$88,883 4 Chief Financial Officer 12 Oct 2021, 20:02
ITOS iTeos Therapeutics, Inc. 24 Jun 2021 1 $0 4 Chief Financial Officer 25 Jun 2021, 20:00
ITOS iTeos Therapeutics, Inc. 16 Jun 2021 1 +$130,446 4 Chief Financial Officer 16 Jun 2021, 18:46